Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 29;3(3):CD012457.
doi: 10.1002/14651858.CD012457.pub2.

Prophylactic antibiotics for preventing infection after continence surgery in women with stress urinary incontinence

Affiliations

Prophylactic antibiotics for preventing infection after continence surgery in women with stress urinary incontinence

Teerayut Temtanakitpaisan et al. Cochrane Database Syst Rev. .

Abstract

Background: Surgical options for treating stress urinary incontinence (SUI) are usually explored after conservative interventions have failed. Surgeries fall into two categories: traditional techniques (open surgery) and minimally invasive procedures, such as laparoscopic procedures, midurethral sling and injections with urethral bulking agents. Postsurgery infections, such as infections of the surgical site or urinary tract, are common complications. To minimise the risk of postoperative bacterial infections, prophylactic antibiotics may be given before or during surgery. OBJECTIVES: To assess the effects of prophylactic antibiotics for preventing infection following continence surgery in women with stress urinary incontinence. SEARCH METHODS: We searched the Cochrane Incontinence Specialised Register, which contains trials identified from CENTRAL, MEDLINE, MEDLINE In-Process, MEDLINE Epub Ahead of Print, CINAHL, ClinicalTrials.gov and WHO ICTRP; and handsearched journals and conference proceedings to 18 March 2021. We also searched the reference lists of relevant articles.

Selection criteria: We included randomised controlled trials (RCTs) and quasi-RCTs assessing prophylactic antibiotics in women undergoing continence surgery to treat SUI.

Data collection and analysis: Two review authors selected potentially eligible trials, extracted data and assessed risk of bias. We expressed results as risk ratios (RR) for dichotomous outcomes and as mean differences (MD) for continuous outcomes, both with 95% confidence intervals (CIs). We assessed the certainty of evidence using the GRADE approach.

Main results: We identified one quasi-RCT and two RCTs, involving a total of 390 women. One study performed retropubic urethropexy surgery requiring a transverse suprapubic incision, while the other two studies performed midurethral sling surgery. It should be noted that none of the included studies clearly specified the timing of outcome assessment. We are very uncertain whether prophylactic antibiotics (cefazolin) have an effect on surgical site infections (RR 0.56, 95% CI 0.03 to 12.35; 2 studies, 85 women; very low-certainty evidence) or urinary tract infections or bacteriuria (RR 0.84, 95% CI 0.05 to 13.24; 2 studies, 85 women; very low-certainty evidence). The effect of prophylactic antibiotics (cefazolin) on febrile morbidity is also uncertain (RR 0.08, 95% CI 0.00 to 1.29; 2 studies, 85 women; very low-certainty evidence). We are very uncertain whether prophylactic antibiotics (cefazolin) have any effect on mesh exposure (RR 0.32, 95% CI 0.01 to 7.61; 1 study, 59 women; very low-certainty evidence). None of the three included studies described the assessment of adverse events from antibiotic use, sepsis or bacteraemia in their reports.

Authors' conclusions: Only limited data are available from the three included studies and, overall, the certainty of evidence was very low. Moreover, the three included studies evaluated different surgical procedures and dosages of antibiotic administration. Thus, there is insufficient evidence to support or refute the use of prophylactic antibiotics to prevent infection following anti-incontinence surgery. In addition, there were no data regarding adverse effects of prophylactic antibiotics. More RCTs are required.

Trial registration: ClinicalTrials.gov NCT01754558 NCT00734968 NCT03898310.

PubMed Disclaimer

Conflict of interest statement

In accordance with Cochrane's Commercial Sponsorship Policy, the following declarations are applicable for the three years prior to the registration of this title.

TT: none known PB: none known PL: none known ML: none known SR: none known

Figures

1
1
Study flow diagram
2
2
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies
3
3
Risk of bias summary: review authors' judgements about each risk of bias item for each included study
1.1
1.1. Analysis
Comparison 1: Antibiotic prophylaxis versus placebo or no treatment, Outcome 1: Surgical site infection
1.2
1.2. Analysis
Comparison 1: Antibiotic prophylaxis versus placebo or no treatment, Outcome 2: Symptomatic UTI or bacteriuria
1.3
1.3. Analysis
Comparison 1: Antibiotic prophylaxis versus placebo or no treatment, Outcome 3: Febrile morbidity
1.4
1.4. Analysis
Comparison 1: Antibiotic prophylaxis versus placebo or no treatment, Outcome 4: Mesh exposure
1.5
1.5. Analysis
Comparison 1: Antibiotic prophylaxis versus placebo or no treatment, Outcome 5: Readmission to hospital
1.6
1.6. Analysis
Comparison 1: Antibiotic prophylaxis versus placebo or no treatment, Outcome 6: Length of hospital stay

Update of

  • doi: 10.1002/14651858.CD012457

Similar articles

References

References to studies included in this review

Bhatia 1989 {published data only}
    1. Bergman A, Bhatia N.Antibiotic prophylaxis in surgery for stress urinary incontinence (Abstract number 16.04.02). Archives of Gynecology 1985;237(1 Suppl):377. [sr-incont8018]
    1. Bhatia NN, Bergman A.Benefit-cost analysis of antibiotic prophylaxis in surgery for stress urinary incontinence. In: International Continence Society (ICS), 15th Annual Meeting, 1985 Sep 3-6; London, UK. Bristol, UK: International Continence Society (ICS), 1985:312-3. [sr-incont10929]
    1. Bhatia NN, Bergman A.Role of antibiotic prophylaxis in surgery for stress urinary incontinence. In: American Urogynecology Society, 6th Annual Meeting, 1985 Nov 6-9; San Diego (CA). Silver Spring (MD): American Urogynecology Society, 1985. [sr-incont14559]
    1. Bhatia NN, Karram MM, Bergman A.Role of antibiotic prophylaxis in retropubic surgery for stress urinary incontinence. Obstetrics and Gynecology 1989;74(4):637-9. [sr-incont437] [PMID: ] - PubMed
Harmanli 2011 {published data only}
    1. Harmanli O, Boyer R, Metz S, Jones K, Tunitsky E.Double-blinded randomized trial of preoperative antibiotics in midurethral sling procedures. In: Joint Meeting of the International Continence Society (ICS) and the International Urogynecological Association (IUGA), 2010 Aug 23-27; Toronto, Canada. Bristol, UK: International Continence Society (ICS), 2010. [Abstract number 1184] [sr-incont40210]
    1. Harmanli O, Boyer RL, Metz S, Tunitsky E, Jones KA.Double-blinded randomized trial of preoperative antibiotics in midurethral sling procedures and review of the literature. International Urogynecology Journal 2011;22(10):1249-53. [DOI: 10.1007/s00192-011-1500-6] [sr-incont42696] - DOI - PubMed
Rudnicki 2020 {published data only}
    1. Rudnicki M, Jakobsson U, Teleman P.Impact of per-operative antibiotics on the urinary tract infection rate following mid-urethral sling surgery for urinary incontinence: a randomized controlled trial. International Urogynecology Journal 2020;31(8):1545-50. [NCT01754558] [PMID: ] - PubMed

References to studies excluded from this review

Childs 1981 {published data only}
    1. Childs SJ, Wood PD, Kosola JW.Antibiotic prophylaxis in genitourinary surgery. Clinical Therapeutics 1981;4 Suppl A:111-23. [sr-incont40811] - PubMed
Childs 1982 {published data only}
    1. Childs SJ, Wood PD, Kosola JW.Antibiotic prophylaxis in genitourinary surgery: a comparison of cefotaxime and cefazolin. Clinical Therapeutics 1982;5 Suppl A:48-57. [sr-incont7546] - PubMed
Childs 1983a {published data only}
    1. Childs SJ, Wells WG, Mirelman S.Antibiotic prophylaxis for genitourinary surgery in community hospitals. Journal of Urology 1983;130(2):305-8. [sr-incont1044] - PubMed
Childs 1983b {published data only}
    1. Childs SJ, Mirelman S, Wells WG.Perioperative use of ceftazidime as a prophylactic agent in transurethral surgery. Journal of Antimicrobial Chemotherapy 1983;12 Suppl A:71-6. [sr-incont642] - PubMed
da Silva 1992 {published data only}
    1. da Silva FC.Prophylactic antibiotherapy in urological surgery. Infection 1992;20 Suppl 3:S221-3. [sr-incont1354] - PubMed
Dieter 2014 {published data only}
    1. Dieter AA, Amundsen CL, Edenfield AL, Kawasaki A, Levin PJ, Visco AG, et al.A randomized controlled trial of suppressive therapy with oral antibiotics to prevent post-operative urinary tract infection: Stopp UTI trial. Female Pelvic Medicine and Reconstructive Surgery 2013;19(5 Suppl):S62. [DOI: 10.1097/SPV.0b013e3182a5ddf0] [sr-incont72784] - DOI
    1. Dieter AA, Amundsen CL, Edenfield AL, Kawasaki A, Levin PJ, Visco AG, et al.Oral antibiotics to prevent postoperative urinary tract infection: a randomized controlled trial [Erratum in: Obstetrics and Gynecology 2014;123(3):669]. Obstetrics and Gynecology 2014;123(1):96-103. [DOI: 10.1097/AOG.0000000000000024] [NCT01450800] [sr-incont60536] - DOI - PubMed
Dorflinger 1984 {published data only}
    1. Dorflinger T, Madsen PO.Antibiotic prophylaxis in transurethral surgery. Urology 1984;24(6):643-6. [sr-incont659] - PubMed
Dorflinger 1985 {published data only}
    1. Dorflinger T, Madsen PO.Antibiotic prophylaxis in transurethral surgery: a comparison of sulbactam-ampicillin and cefoxitin. Infection 1985;13(2):66-9. [sr-incont7476] - PubMed
Gasser 1996 {published data only}
    1. Gasser TC, Wisard M, Frei R.Oral fleroxacin prophylaxis in transurethral surgery. Journal of Urology 1996;156(1):146-8. [sr-incont6853] - PubMed
Jackson 2013 {published data only}
    1. Jackson D, Higgins E, Bracken J, Yandell P, Shull B, Foster RT.Urinary prophylaxis after midurethral sling to prevent UTI-a double blinded, placebo controlled, multicenter, randomized controlled trial. Female Pelvic Medicine and Reconstructive Surgery 2011;17(5 Suppl 1):S52. [DOI: 10.1097/SPV.0b013e31822c9e8a] [NCT00734968] [sr-incont71153] - DOI
    1. Jackson D, Higgins E, Bracken J, Yandell PM, Shull B, Foster RT Sr.Antibiotic prophylaxis for urinary tract infection after midurethral sling: a randomized controlled trial. Female Pelvic Medicine and Reconstructive Surgery 2013;19(3):137-41. [DOI: 10.1097/SPV.0b013e318285ba53] [NCT00734968] [sr-incont48136] - DOI - PubMed
    1. NCT00734968.Does treatment with macrobid reduce urinary tract infections in patients receiving a sub-urethral sling for incontinence [Does prophylaxis with macrobid reduce the incidence of urinary tract infection in patients who receive a sub-urethral sling for the treatment of stress urinary incontinence: randomized, double blinded placebo controlled clinical trial]. clinicaltrials.gov/show/NCT00734968 (first received 14 August 2008). [NCT00734968] [sr-incont63741]
Kaplan 1969 {published data only}
    1. Kaplan GW, Belman AB, Kropp KA.A double blind study of sulfa prophylaxis after transurethral resection. Investigative Urology 1969;7(2):181-4. [sr-incont884] - PubMed
Korbel 1976 {published data only}
    1. Korbel EI, Maher PO.Use of prophylactic antibiotics in urethral instrumentation. Journal of Urology 1976;116(6):744-6. [sr-incont836] - PubMed
McLennan 2004 {published data only}
    1. McLennan MT, Theofrastous JP, Melick CF.Randomized trial of cefazolin prophylaxis for open Burch retropubic urethropexy. Journal of Pelvic Medicine and Surgery 2004;10(5):239-44. [sr-incont21146]
Mouquet 1987 {published data only}
    1. Mouquet C, Fusciardi J, Stoupak MP, Vallancien G, Jarlier V, Chatelain C, et al.Transurethral surgery and persistent urinary infection: effect of a single preoperative dose of cefuroxime [Chirurgie transuréthrale et infection urinaire persistante: effet d'une dose unique preéopératoire de céfuroxime]. Pathologie-biologie 1987;35(9):1243-7. [sr-incont517] - PubMed
NCT03898310 {published data only}
    1. NCT03898310, Quiroz L.UTI prophylaxis with cranberry extract after female incontinence surgery. clinicaltrials.gov/ct2/show/study/NCT03898310 (first received 1 April 2019). [NCT03898310] [sr-incont78462]
Rechberger 2020 {published data only}
    1. Rechberger E, Rechberger T, Wawrysiuk S, Miotla P, Kulik-Rechberger B, Kuszka A, et al.A randomized clinical trial to evaluate the effect of canephron N in comparison to ciprofloxacin in the prevention of postoperative lower urinary tract infections after midurethral sling surgery. Journal of Clinical Medicine 2020;9(11):3391. [PMID: ] - PMC - PubMed
Rinker 1969 {published data only}
    1. Rinker JR, Witherington R.Prophylactic effect of nitrofurantoin (furadantin) in urologic procedures. Southern Medical Journal 1969;62(8):960-1. [sr-incont944] - PubMed
Rogers 2004 {published data only}
    1. Rogers R, Kammerer-Doak D, Olsen A, Thompson P, Walters M, Lukacz M.A randomized double-blind placebo controlled comparison of the effect of nitrofurantoin monohydrate on the development of urinary tract infections following surgery for pelvic organ prolapse and/or genuine stress urinary incontinence with suprapubic catheter. In: International Continence Society (ICS), 33rd Annual Meeting, 2003 Oct 5-9; Florence Italy. Bristol, UK: International Continence Society (ICS), 2003:507-8. [sr-incont16994]
    1. Rogers RG, Kammerer-Doak D, Olsen A, Thompson PK, Walters MD, Lukacz ES, et al.A randomized, double-blind, placebo-controlled comparison of the effect of nitrofurantoin monohydrate macrocrystals on the development of urinary tract infections after surgery for pelvic organ prolapse and/or stress urinary incontinence with suprapubic catheterization. American Journal of Obstetrics and Gynecology 2004;191(1):182-7. [sr-incont20940] - PubMed
Sanaee 2019 {published data only}
    1. Sanaee MS, Hutcheon JA, Larouche M, Brown HL, Lee T, Geoffrion R.Urinary tract infection prevention after midurethral slings in pelvic floor reconstructive surgery: a systematic review and meta-analysis. Acta Obstetricia et Gynecologica Scandinavica 2019;98(12):1514-22. [PMID: ] - PubMed
Shepherd 2014 {published data only}
    1. Shepherd JP, Jones KA, Harmanli O.Is antibiotic prophylaxis necessary before midurethral sling procedures for female stress incontinence? A decision analysis. International Urogynecology Journal 2014;25(2):227-33. [DOI: 10.1007/s00192-013-2180-1] [sr-incont50379] - DOI - PubMed
    1. Shepherd JP, Jones KA, Harmanli O.Is antibiotic prophylaxis necessary prior to midurethral sling procedures in women with stress urinary incontinence? A decision analysis. Female Pelvic Medicine and Reconstructive Surgery 2012;18(5 Suppl 2):S180-1. [DOI: 10.1097/SPV.0b013e31826abf55] [sr-incont70958] - DOI
Van Eyk 2012b {published data only}
    1. Van Eyk N, Schalkwyk J, Yudin MH, Allen VM, Bouchard C, Boucher M, et al, Infectious Diseases Committee.Antibiotic prophylaxis in gynaecologic procedures. Journal of Obstetrics and Gynaecology Canada: JOGC (Journal d'obstétrique et gynécologie du Canada: JOGC) 2012;34(4):382-91. [sr-incont44702] - PMC - PubMed

Additional references

ACOG 2018
    1. American College of Obstetricians and Gynecologists' Committee on Practice Bulletins – Gynecology.ACOG practice bulletin No. 195: Prevention of infection after gynecologic procedures. Obstetrics and Gynecology 2018;131(6):e172‐e189. [DOI: 10.1097/AOG.0000000000002670 ] - PubMed
Akkus 2016
    1. Akkus Y, Pinar G.Evaluation of the prevalence, type, severity, and risk factors of urinary incontinence and its impact on quality of life among women in Turkey. International Urogynecology Journal 2016;27(6):887-93. [DOI: 10.1007/s00192-015-2904-5] [PMID: ] - DOI - PubMed
Chai 2009
    1. Chai TC, Albo ME, Richter HE, Norton PA, Dandreo KJ, Kenton K, et al, Urinary Incontinence Treatment Network.Complications in women undergoing Burch colposuspension versus autologous rectus fascial sling for stress urinary incontinence. Journal of Urology 2009;181(5):2192-7. - PMC - PubMed
Covidence [Computer program]
    1. Covidence.Version accessed 18 March 2021. Melbourne, Australia: Veritas Health Innovation. Available at covidence.org.
Coyne 2012
    1. Coyne KS, Kvasz M, Ireland AM, Milsom I, Kopp ZS, Chapple CR.Urinary incontinence and its relationship to mental health and health-related quality of life in men and women in Sweden, the United Kingdom, and the United States. European Urology 2012;61(1):88-95. - PubMed
Davis 2013
    1. Davis NF, Kheradmand F, Creagh T.Injectable biomaterials for the treatment of stress urinary incontinence: their potential and pitfalls as urethral bulking agents. International Urogynecology Journal 2013;24(6):913-9. - PubMed
Deeks 2001
    1. Deeks J, Altman DG, Bradburn MJ.Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG, editors(s). Systematic Reviews in Health Care: Meta-Analysis in Context. 2nd edition. London, UK: BMJ Publishing Group, 2001:285–312.
DerSimonian 1986
    1. DerSimonian R, Laird N.Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-88. - PubMed
Dieter 2012
    1. Dieter AA, Amundsen CL, Visco AG, Siddiqui NY.Treatment for urinary tract infection after midurethral sling: a retrospective study comparing patients who receive short-term postoperative catheterization and patients who pass a void trial on the day of surgery. Female Pelvic Medicine and Reconstructive Surgery 2012;18(3):175-8. - PubMed
EndNote 2018 [Computer program]
    1. EndNote.Version X8.2. Philadelphia (PA): Clarivate Analytics, 2018.
EndNote 2020 [Computer program]
    1. EndNote.Version 20. Philadelphia (PA): Clarivate Analytics, 2020. Available at endnote.com.
GRADEpro GDT [Computer program]
    1. GRADEpro GDT.Version accessed 28 January 2022. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.
Harmanli 2012
    1. Harmanli O, Hong EK, Rubin R, Jones KA, Boyer RL, Metz S.Is antibiotic prophylaxis necessary for midurethral sling procedures? A series of 174 cases without preoperative antibiotics. International Urogynecology Journal 2012;23(5):621-3. - PubMed
Haylen 2010
    1. Haylen BT, Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al.An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. International Urogynecology Journal 2010;21(1):5-26. [PMID: ] - PubMed
Higgins 2003
    1. Higgins JP, Thompson SG, Deeks JJ, Altman DG.Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60. - PMC - PubMed
Higgins 2011
    1. Higgins JP, Green S, editor(s).Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Higgins 2021
    1. Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s).Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.
Kietpeerakool 2017
    1. Kietpeerakool C, Chumworathayi B, Thinkhamrop J, Ussahgij B, Lumbiganon P.Antibiotics for infection prevention after excision of the cervical transformation zone. Cochrane Database of Systematic Reviews 2017, Issue 1. Art. No: CD009957. [DOI: 10.1002/14651858.CD009957.pub2] - DOI - PMC - PubMed
Köckerling 2015
    1. Köckerling F, Bittner R, Jacob D, Schug-Pass C, Laurenz C, Adolf D, et al.Do we need antibiotic prophylaxis in endoscopic inguinal hernia repair? Results of the Herniamed Registry. Surgical Endoscopy 2015;29(12):3741-9. - PMC - PubMed
Mainprize 1988
    1. Mainprize TC, Drutz HP.The Marshall-Marchetti-Krantz procedure: a critical review. Obstetrical and Gynecological Survey 1988;43(12):724-9. - PubMed
NICE 2019
    1. National Collaborating Centre for Women's and Children's Health (UK), NHS National Institute for Health and Clinical Excellence (NICE).Urinary incontinence: the management of urinary incontinence in women. NICE Clinical Guideline (NG123). Available at www.nice.org.uk/guidance/ng123 2019.
Pevzner 2011
    1. Pevzner L, Swank M, Krepel C, Wing DA, Chan K, Edmiston CE Jr.Effects of maternal obesity on tissue concentrations of prophylactic cefazolin during cesarean delivery. Obstetrics and Gynecology 2011;117(4):877-82. - PubMed
Review Manager 2020 [Computer program]
    1. Review Manager 5 (RevMan 5).Version 5.4.1. The Cochrane Collaboration, 2020.
Rudnicki 2017
    1. Rudnicki M, Bothmer-Ostling K, Holstad A, Magnusson C, Majida M, Merkel C, et al.Adjustable mini-sling compared with conventional mid-urethral slings in women with urinary incontinence. A randomized controlled trial. Acta Obstetricia et Gynecologica Scandinavica 2017;96(11):1347-56. - PubMed
Schiøtz 2002
    1. Schiøtz HA, Guttu K.Value of urinary prophylaxis with methenamine in gynecologic surgery. Acta Obstetricia et Gynecologica Scandinavica 2002;81(8):743-6. - PubMed
Schünemann 2021
    1. Schünemann HJ, Higgins JPT, Vist GE, Glasziou P, Akl EA, Skoetz N, et al.Chapter 14: Completing ‘Summary of findings’ tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook.
Sterne 2011
    1. Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al.Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011;343:d4002. [DOI: 10.1136/bmj.d4002 ] - PubMed
Swartz 2010
    1. Swartz M, Ching C, Gill B, Li J, Rackley R, Vasavada S, et al.Risk of infection after midurethral synthetic sling surgery: are postoperative antibiotics necessary? Urology 2010;75(6):1305-8. - PubMed
Tanos 1994
    1. Tanos V, Rojansky N.Prophylactic antibiotics in abdominal hysterectomy. Journal of the American College of Surgeons 1994;179(5):593-600. - PubMed
Van Eyk 2018
    1. Van Eyk N, Schalkwyk J.No. 275 – Antibiotic prophylaxis in gynaecologic procedures. Journal of Obstetrics and Gynaecology Canada: JOGC [Journal d'Obstetrique et Gynecologie du Canada: JOGC] 2018;40(10):e723‐33. [DOI: 10.1016/j.jogc.2018.07.007] - DOI - PubMed
Zoorob 2012
    1. Zoorob D, Karram M.Bulking agents: a urogynecology perspective. Urologic Clinics of North America 2012;39(3):273-7. - PubMed

References to other published versions of this review

Temtanakitpaisan 2016
    1. Temtanakitpaisan T, Buppasiri P, Chongsomchai C, Kietpeerakool C, Lumbiganon P, Laopaiboon M.Antibiotics for the prevention of infection after continence surgery in women with stress urinary incontinence. Cochrane Database of Systematic Reviews 2016, Issue 12. Art. No: CD012457. [DOI: 10.1002/14651858.CD012457] - DOI - PMC - PubMed

Publication types

Substances

Associated data